NCT03121573View on ClinicalTrials.gov

Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 15, 2014

Primary Completion Date

September 26, 2016

Study Completion Date

January 17, 2017

Conditions
Major Depressive Disorder
Interventions
DRUG

Duloxetine

duloxetine 30 to 60 mg tablets by mouth, QD to BID per day,

All Listed Sponsors
lead

Taichung Veterans General Hospital

OTHER

NCT03121573 - Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial | Biotech Hunter | Biotech Hunter